198 related articles for article (PubMed ID: 7507539)
1. ACE inhibitors: future perspectives.
Reid JL
J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S41-3. PubMed ID: 7507539
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies of tissue inhibition by angiotensin converting enzyme inhibitors.
Johnston CI; Fabris B; Yamada H; Mendelsohn FA; Cubela R; Sivell D; Jackson B
J Hypertens Suppl; 1989 Sep; 7(5):S11-6. PubMed ID: 2553899
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibition: prospects for the future.
Jackson B; Mendelsohn FA; Johnston CI
J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S4-8. PubMed ID: 1725200
[TBL] [Abstract][Full Text] [Related]
4. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
5. [What have we learned from converting enzyme inhibitors on renin-angiotensin system?].
Waeber B; Nussberger J; Brunner HR
Rev Prat; 1992 Dec; 42(20):2529-32. PubMed ID: 1338608
[TBL] [Abstract][Full Text] [Related]
6. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
[TBL] [Abstract][Full Text] [Related]
7. [Relations between pharmacokinetics and effectiveness of ACE inhibitors].
Rettig R; Gohlke P; Unger T
Z Kardiol; 1991; 80 Suppl 2():16-20. PubMed ID: 2024539
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition.
Hingorani AD; Jia H; Stevens PA; Hopper R; Dickerson JE; Brown MJ
J Hypertens; 1995 Dec; 13(12 Pt 2):1602-9. PubMed ID: 8903618
[TBL] [Abstract][Full Text] [Related]
9. Endothelial function, fibrinolysis, and angiotensin-converting enzyme inhibition.
Vaughan DE
Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-34-7. PubMed ID: 9422850
[TBL] [Abstract][Full Text] [Related]
10. The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors.
Ganten D; Mullins J; Lindpaintner K
J Hum Hypertens; 1989 Jun; 3 Suppl 1():63-70. PubMed ID: 2674443
[TBL] [Abstract][Full Text] [Related]
11. High affinity binding sites for Perindopril a new inhibitor of angiotensin-I-converting enzyme (ACE) in the rabbit kidney: possible evidence for localization of ACE in endothelial structures and in glomerular mesangium.
Morin JP; Moulin B; Borghi H; Fillastre JP
Int J Tissue React; 1989; 11(2):81-92. PubMed ID: 2559047
[TBL] [Abstract][Full Text] [Related]
12. [Mechanisms of action of angiotensin I converting enzyme inhibitors].
Wiecek A
Przegl Lek; 1994; 51(4):193-7. PubMed ID: 8058992
[TBL] [Abstract][Full Text] [Related]
13. Effects of idrapril calcium on tissue angiotensin-converting enzyme in rats.
Becagli P; Lippi A; Criscuoli M; Breschi MC; Subissi A
J Cardiovasc Pharmacol; 1995 Jul; 26(1):27-32. PubMed ID: 7564361
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
15. Circulating versus local renin-angiotensin system in cardiovascular homeostasis.
Dzau VJ
Circulation; 1988 Jun; 77(6 Pt 2):I4-13. PubMed ID: 3286045
[TBL] [Abstract][Full Text] [Related]
16. [Growth stimulating properties of angiotensin II on the heart: consequences for therapy of heart failure].
Schunkert H; Holmer SR; Riegger G
Z Kardiol; 1993; 82 Suppl 4():1-6. PubMed ID: 8147057
[TBL] [Abstract][Full Text] [Related]
17. Tissue renin angiotensin systems: theoretical implications for the development of hyperkalemia using angiotensin-converting enzyme inhibitors.
Schlueter W; Keilani T; Batlle DC
Am J Med Sci; 1994 Feb; 307 Suppl 1():S81-6. PubMed ID: 8141171
[TBL] [Abstract][Full Text] [Related]
18. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
[TBL] [Abstract][Full Text] [Related]
19. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
[TBL] [Abstract][Full Text] [Related]
20. Clinical potential: angiotensin converting enzyme inhibitor or angiotensin II antagonist?
McInnes GT
J Hypertens Suppl; 2001 Jun; 19(1):S61-7. PubMed ID: 11451217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
